AV Therapeutics, Inc. — Form D/A
AV Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2014-05-22. The offering totals $3.5M, of which $1.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-05-22
- Form: D/A
- Accession: 0001185185-14-001416
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $1.3M
- Remaining: $2.2M
- Investors: 9
- Date of first sale: 2013-12-13
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-208906
Issuer
- Name: AV Therapeutics, Inc.
- CIK: 0001537293
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 20 EAST 68TH STREET, NEW YORK, NY, 10065
- Phone: 212-288-2763
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Abraham Mittelman | Director | New York, NY |
| Raj Kumar Tiwari | Director | New York, NY |
| Morton Coleman | Executive Officer | New York, NY |
| Banerjee Kumar Debabrata | Executive Officer | New York, NY |
| Jan Kumar Geliebter | Executive Officer | New York, NY |
| Abraham Mittelman | Executive Officer | New York, NY |
| Robert Pollock | Executive Officer | New York, NY |
| Raj Kumar Tiwari | Executive Officer | New York, NY |
| Doug Kumar Cole | Director | New York, NY |
Other filings by this issuer (1)
More